← Back to Search

Calcium Supplements for Osteoporosis

Phase < 1
Recruiting
Led By Sarah J Wherry, PhD
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Currently taking a bisphosphonate medication
Healthy adults aged 60-80 y
Must not have
Moderate or severe renal impairment defined as an estimated glomerular filtration rate of <60 mL/min/1.73m2 based on the Modified Diet in Renal Disease (MDRD) equation
Use of medications (other than bisphosphonates) in the past 6 months known to affect bone metabolism (e.g., thiazide diuretics, oral glucocorticoids)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at baseline, through 60 minutes of exercise, and during 4 hours of recovery
Awards & highlights
Approved for 10 Other Conditions
All Individual Drugs Already Approved

Summary

This trial will test if a "calcium clamp" can prevent bone breakdown during exercise by keeping calcium levels stable.

Who is the study for?
This trial is for healthy adults aged 60-80 who are currently taking bisphosphonates for osteoporosis. It's not suitable for those on other bone-affecting meds, with severe osteoporosis, uncontrolled high blood pressure, liver or kidney issues, diabetes, thyroid dysfunction, asthma or heart disease.
What is being tested?
The study tests if using a 'calcium clamp' to prevent drops in serum calcium during exercise can also stop increases in markers of bone loss. Participants will receive either Calcium Chloride/Calcium Gluconate or a placebo while exercising.
What are the potential side effects?
Potential side effects may include reactions at the infusion site due to calcium administration such as warmth or discomfort and possible changes in blood pressure. Long-term effects on bone health are being studied.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am currently on bisphosphonate medication.
Select...
I am a healthy adult between 60 and 80 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My kidney function is reduced, with a filtration rate below 60 mL/min.
Select...
I haven't taken any medications that affect bone health, except for bisphosphonates, in the last 6 months.
Select...
I have a condition that affects how my intestines absorb nutrients.
Select...
I have asthma.
Select...
I have a history of diabetes.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at baseline, through 60 minutes of exercise, and during 4 hours of recovery
This trial's timeline: 3 weeks for screening, Varies for treatment, and at baseline, through 60 minutes of exercise, and during 4 hours of recovery for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Parathyroid Hormone (PTH)
Secondary study objectives
Change in C-telopeptide (CTX)
Change in Total Calcium (Ca)

Awards & Highlights

Approved for 10 Other Conditions
This treatment demonstrated efficacy for 10 other conditions.
All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Calcium InfusionExperimental Treatment1 Intervention
Continuous calcium infusion during exercise
Group II: Saline InfusionPlacebo Group1 Intervention
Continuous saline infusion during exercise

Find a Location

Who is running the clinical trial?

National Center for Advancing Translational Sciences (NCATS)NIH
371 Previous Clinical Trials
412,881 Total Patients Enrolled
1 Trials studying Osteoporosis
48 Patients Enrolled for Osteoporosis
University of Colorado, DenverLead Sponsor
1,806 Previous Clinical Trials
2,822,842 Total Patients Enrolled
11 Trials studying Osteoporosis
1,091 Patients Enrolled for Osteoporosis
Sarah J Wherry, PhDPrincipal InvestigatorUniversity of Colorado, Denver
3 Previous Clinical Trials
170 Total Patients Enrolled
3 Trials studying Osteoporosis
170 Patients Enrolled for Osteoporosis
~3 spots leftby Nov 2025